Yoav Timsit

926 total citations
15 papers, 581 citations indexed

About

Yoav Timsit is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yoav Timsit has authored 15 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yoav Timsit's work include Pharmacogenetics and Drug Metabolism (3 papers), Adipose Tissue and Metabolism (3 papers) and Estrogen and related hormone effects (3 papers). Yoav Timsit is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Adipose Tissue and Metabolism (3 papers) and Estrogen and related hormone effects (3 papers). Yoav Timsit collaborates with scholars based in United States, Canada and Switzerland. Yoav Timsit's co-authors include Masahiko Negishi, David S. Riddick, Chunja Lee, Anahita Bhathena, John Y.L. Chiang, Edward T. Morgan, Russell A. Prough, Po‐Yung Cheng, Sharon L. Ripp and Kristy K. Michael Miller and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Cancer Research.

In The Last Decade

Yoav Timsit

15 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoav Timsit United States 11 268 198 158 127 115 15 581
Marie José Vilarem France 8 193 0.7× 169 0.9× 126 0.8× 128 1.0× 107 0.9× 9 606
Caitlin Lynch United States 14 171 0.6× 154 0.8× 91 0.6× 88 0.7× 94 0.8× 26 464
Mengxi Jiang United States 15 166 0.6× 269 1.4× 152 1.0× 118 0.9× 114 1.0× 24 672
Lucia F. Jorge-Nebert United States 9 276 1.0× 186 0.9× 137 0.9× 44 0.3× 64 0.6× 11 583
Jillian Ross United Kingdom 6 268 1.0× 132 0.7× 137 0.9× 105 0.8× 83 0.7× 7 426
Michel Kaufmann Switzerland 10 294 1.1× 327 1.7× 233 1.5× 191 1.5× 137 1.2× 11 745
Anja Rode United Kingdom 14 362 1.4× 303 1.5× 239 1.5× 103 0.8× 149 1.3× 15 758
Xiulong Song United States 18 218 0.8× 259 1.3× 407 2.6× 83 0.7× 65 0.6× 25 865
Yonggong Zhai China 5 160 0.6× 301 1.5× 182 1.2× 175 1.4× 107 0.9× 5 719
Chunja Lee Canada 14 175 0.7× 191 1.0× 170 1.1× 45 0.4× 53 0.5× 22 494

Countries citing papers authored by Yoav Timsit

Since Specialization
Citations

This map shows the geographic impact of Yoav Timsit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Timsit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Timsit more than expected).

Fields of papers citing papers by Yoav Timsit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Timsit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Timsit. The network helps show where Yoav Timsit may publish in the future.

Co-authorship network of co-authors of Yoav Timsit

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Timsit. A scholar is included among the top collaborators of Yoav Timsit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Timsit. Yoav Timsit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Brennan, Richard, Stephen Jenkinson, Andrew J. Brown, et al.. (2024). Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature Reviews Drug Discovery. 23(7). 563–563. 2 indexed citations
2.
Brennan, Richard, Stephen Jenkinson, Andrew J. Brown, et al.. (2024). The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature Reviews Drug Discovery. 23(7). 525–545. 14 indexed citations
3.
Pognan, François, Chiara Buono, Philippe Couttet, et al.. (2022). Liver enzyme delayed clearance in rat treated by CSF1 receptor specific antagonist Sotuletinib. Current Research in Toxicology. 3. 100091–100091. 7 indexed citations
4.
Schalm, Stefanie S., John Campbell, Jian Guo, et al.. (2022). Abstract 3328: Antitumor activity of BLU-945 and BLU-701 as single agents and in combination in EGFR L858R-driven models of NSCLC. Cancer Research. 82(12_Supplement). 3328–3328. 9 indexed citations
5.
Pognan, François, Philippe Couttet, Yinuo Pang, et al.. (2019). Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes. Journal of Pharmacology and Experimental Therapeutics. 369(3). 428–442. 17 indexed citations
6.
Timsit, Yoav & Masahiko Negishi. (2014). Coordinated Regulation of Nuclear Receptor CAR by CCRP/DNAJC7, HSP70 and the Ubiquitin-Proteasome System. PLoS ONE. 9(5). e96092–e96092. 31 indexed citations
7.
Timsit, Yoav, Chika Koike, Kenji Matsui, et al.. (2007). Overexpression of the Rho‐guanine nucleotide exchange factor ECT2 inhibits nuclear translocation of nuclear receptor CAR in the mouse liver. FEBS Letters. 581(25). 4937–4942. 7 indexed citations
8.
Timsit, Yoav & Masahiko Negishi. (2006). CAR and PXR: The xenobiotic-sensing receptors☆. Steroids. 72(3). 231–246. 337 indexed citations
9.
Timsit, Yoav, Stephanie L. Miller, Robert P. Mohney, & John P. O’Bryan. (2005). The U-box ligase carboxyl-terminus of Hsc 70-interacting protein ubiquitylates Epsin. Biochemical and Biophysical Research Communications. 328(2). 550–559. 11 indexed citations
10.
Riddick, David S., Chunja Lee, Anahita Bhathena, et al.. (2004). TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS. Drug Metabolism and Disposition. 32(4). 367–375. 79 indexed citations
11.
Riddick, David S., Chunja Lee, Anahita Bhathena, & Yoav Timsit. (2003). The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons. Canadian Journal of Physiology and Pharmacology. 81(1). 59–77. 13 indexed citations
12.
Timsit, Yoav. (2002). Aromatic Hydrocarbon Receptor Expression and Function in Liver of Hypophysectomized Male Rats. Toxicology and Applied Pharmacology. 185(2). 136–145. 13 indexed citations
13.
Timsit, Yoav & David S. Riddick. (2002). Stimulation of Hepatic Signal Transducer and Activator of Transcription 5b by GH Is Not Altered by 3-Methylcholanthrene. Endocrinology. 143(9). 3284–3294. 10 indexed citations
14.
Timsit, Yoav & David S. Riddick. (2000). Interference with Growth Hormone Stimulation of Hepatic Cytochrome P4502C11 Expression in Hypophysectomized Male Rats by 3-Methylcholanthrene. Toxicology and Applied Pharmacology. 163(2). 105–114. 17 indexed citations
15.
Leeder, J. Steven, Xiaoli Lü, Yoav Timsit, & Andrea Gaedigk. (1998). Non-monooxygenase cytochromes P450 as potential human autoantigens in anticonvulsant hypersensitivity reactions. Pharmacogenetics. 8(3). 211–226. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026